Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yali Wang, Erik De Clercq & Guangdi Li. (2019) Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment. Expert Opinion on Drug Metabolism & Toxicology 15:10, pages 813-829.
Read now
Read now
Dario Cattaneo, Amedeo Capetti & Giuliano Rizzardini. (2019) Drug–drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment. Expert Opinion on Drug Metabolism & Toxicology 15:3, pages 245-252.
Read now
Read now
Eugènia Negredo & Bonaventura Clotet. (2018) Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1. Expert Opinion on Pharmacotherapy 19:8, pages 929-934.
Read now
Read now
Laura Benítez-Gutiérrez, Vicente Soriano, Silvia Requena, Ana Arias, Pablo Barreiro & Carmen de Mendoza. (2018) Treatment and prevention of HIV infection with long-acting antiretrovirals. Expert Review of Clinical Pharmacology 11:5, pages 507-517.
Read now
Read now
Barbara Rossetti, Francesca Montagnani & Andrea De Luca. (2018) Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients. Expert Opinion on Pharmacotherapy 19:7, pages 713-738.
Read now
Read now
Amedeo F. Capetti, Maria V. Cossu, Laura Paladini & Giuliano Rizzardini. (2018) Dolutegravir plus rilpivirine dual therapy in treating HIV-1 infection. Expert Opinion on Pharmacotherapy 19:1, pages 65-77.
Read now
Read now
Articles from other publishers (33)
Fabrizio Carta & Mario Sechi. 2024. Metalloenzymes. Metalloenzymes
35
50
.
Mariacristina Poliseno, Maria MazzitelliArianna NarducciSergio Maria FerraraChiara Resnati, Cristina GervasoniAnna Maria CattelanSergio Lo Caputo. (2023) Doravirine Plus Integrase Strand Transfer Inhibitors as a 2-Drug Treatment–Switch Strategy in People Living with HIV: The Real-Life DORINI Multicentric Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 94:3, pages 235-243.
Crossref
Crossref
Prasanta Kumar Mohapatra, Rajnish Srivastava, Krishna Kumar Varshney, Sunit Kumar Sahoo & Asha Kesari. (2023) A Computational Approach for Exploring Indinavir as a Potent Protease Inhibitor and Development of Its Microsphere for Anticancer Activity. Journal of Pharmaceutical Innovation.
Crossref
Crossref
Gioele Renzi, Fabrizio Carta & Claudiu T. Supuran. (2023) The Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario. International Journal of Molecular Sciences 24:15, pages 12187.
Crossref
Crossref
A Coates. (2023) Research pre-empting parasite adaptation is key to sustainable disease management in aquaculture. Aquaculture Environment Interactions 15, pages 35-43.
Crossref
Crossref
Louis S. Matza, Timothy A. Howell, Vasiliki Chounta & Nicolas van de Velde. (2022) Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV. Quality of Life Research 32:2, pages 531-541.
Crossref
Crossref
Svatava Snopková, Petr Husa & Šárka Kozáková. (2022) Is pharmacological eradication of HIV possible?. Klinická farmakologie a farmacie 36:3, pages 93-100.
Crossref
Crossref
Laia Pérez-Cordón, Azhara Sánchez, Sergio Marin, Lluis Force, Mateu Serra-Prat, Elisabet Palomera & Lluis Campins. (2022) Real-world effectiveness and durability of dual antiretroviral therapy in HIV-infected patients. European Journal of Hospital Pharmacy, pages ejhpharm-2022-003277.
Crossref
Crossref
Naidoo J, Hurrell T & Scholefield J. (2022) IPSC-derived models in Africa: An HIV perspective. Biochimie 196, pages 153-160.
Crossref
Crossref
Prem Kumar Kushwaha, Kumar Saurabh Srivastava, Neha Kumari, Rajan Kumar, Debashis Mitra & Ashoke Sharon. (2022) Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs. Bioorganic & Medicinal Chemistry 56, pages 116612.
Crossref
Crossref
Roland Landman, Pierre de Truchis, Lambert Assoumou, Sidonie Lambert, Jonathan Bellet, Karine Amat, Bénédicte Lefebvre, Clotilde Allavena, Christine Katlama, Yazdan Yazdanpanah, Jean-Michel Molina, Ventzislava Petrov-Sanchez, Séverine Gibowski, Jean-Claude Alvarez, Jacques Leibowitch, Jacqueline Capeau, Soraya Fellahi, Martin Duracinsky, Laurence Morand-Joubert, Dominique Costagliola, Pierre-Marie Girard, Isabelle LAMAURY, Firouzé BANI-SADR, Gilles FORCE, Amélie CHABROL, Fabienne CABY, Olivier PATEY, Anne FRESARD, Amandine GAGNEUX-BRUNON, Catherine CHIROUZE, Claudine DUVIVIER, Jérémie LOURENCO, Violaine TOLSMA, Cécile JANSSEN, Nathalie LEROLLE, Pilartxo CATALAN, Agathe RAMI, Lucile DE PONTHAUD, Gilles PICHANCOURT, Safa NASRI, Stéphanie LANDOWSKI, Julie BOTTERO, Flory MFUTILA KAYKAY, Gilles PIALOUX, Olivier BOUCHAUD, Sophie ABGRALL, Caroline GATEY, Laurence WEISS, Juliette PAVIE, Dominique SALMON-CERON, David ZUCMAN, Jean-Daniel LELIEVRE, Romain PALICH, Anne SIMON, Marie-Caroline MEYOHAS, Julien GRAS, André CABIE, Mathilde PIRCHER, Philippe MORLAT, Mojgam HESSAMFAR, Didier NEAU, Charles CAZENAVE, Claire GENET, Jean-François FAUCHER, Djamila MAKHLOUFI, André BOIBIEUX, Sylvie BREGIGEON-RONOT, Hélène LAROCHE, Aurélie SAUTEREAU, Jacques REYNES, Alain MAKINSON, François RAFFI, Olivier BOLLENGIER-STRAGIER, Alissa NAQVI, Eric CUA, Eric ROSENTHAL, Cédrick ARVIEUX, Rodolphe BUZELE, David REY, Marie-Laure BATARD, Louis BERNARD, Pierre DELOBEL, Marie PIFFAUT, Renaud VERDON, Lionel PIROTH, Mathieu BLOT, Pascale LECLERCQ, Anne SIGNORI-SCHMUCK, Thomas HULEUX, Agnès MEYBECK, Thierry MAY, Patrick MIAILHES, Thomas PERPOINT, Alix GREDER-BELAN, Brigitte ELHARRAR, Marie-Aude KHUONG, Marie POUPARD, Laurent BLUM, Christophe MICHAU, Thierry PRAZUCK, Patrick PHILIBERT, Laurence SLAMA, Hitoto HIKOMBO, Iuliana DARASTEANU, Pierre-Marie GIRARD, Jean-Claude ALVAREZ, Dominique MATHEZ, Pierre DE TRUCHIS, Roland LANDMAN, Jean-Luc MEYNARD, Laurence MORAND-JOUBERT, Sidonie LAMBERT, Damien LE DU, Christian PERRONNE, Lambert ASSOUMOU, Dominique COSTAGLIOLA, Jean-Claude MELCHIOR, Martin DURACINSKI, Ventzislava PETROV-SANCHEZ, Karine AMAT, Aïda BENALYCHERIF, Babacar SYLLA, Ambre GELLEY, Séverine GIBOWSKI, Guillaume LE MEUT, Rodolphe THIEBAUT, Nathan CLUMECK, Vincent LECLERCQ, Francesca CECCHERINI-SILBERSTEIN, Laurent DECOSTER, Isabelle LAMAURY, Firouzé BANI-SADR, Gilles FORCE, Amélie CHABROL, Fabienne CABY, Olivier PATEY, Anne FRESARD, Amandine GAGNEUX-BRUNON, Catherine CHIROUZE, Claudine DUVIVIER, Jérémie LOURENCO, Violaine TOLSMA, Cécile JANSSEN, Nathalie LEROLLE, Pilartxo CATALAN, Agathe RAMI, Lucile DE PONTHAUD, Gilles PICHANCOURT, Safa NASRI, Stéphanie LANDOWSKI, Julie BOTTERO, Flory MFUTILA KAYKAY, Gilles PIALOUX, Olivier BOUCHAUD, Sophie ABGRALL, Caroline GATEY, Laurence WEISS, Juliette PAVIE, Dominique SALMON-CERON, David ZUCMAN, Jean-Daniel LELIEVRE, Romain PALICH, Anne SIMON, Marie-Caroline MEYOHAS, Julien GRAS, André CABIE, Mathilde PIRCHER, Philippe MORLAT, Mojgam HESSAMFAR, Didier NEAU, Charles CAZENAVE, Claire GENET, Jean-François FAUCHER, Djamila MAKHLOUFI, André BOIBIEUX, Sylvie BREGIGEON-RONOT, Hélène LAROCHE, Aurélie SAUTEREAU, Jacques REYNES, Alain MAKINSON, François RAFFI, Olivier BOLLENGIER-STRAGIER, Alissa NAQVI, Eric CUA, Eric ROSENTHAL, Cédrick ARVIEUX, Rodolphe BUZELE, David REY, Marie-Laure BATARD, Louis BERNARD, Pierre DELOBEL, Marie PIFFAUT, Renaud VERDON, Lionel PIROTH, Mathieu BLOT, Pascale LECLERCQ, Anne SIGNORI-SCHMUCK, Thomas HULEUX, Agnès MEYBECK, Thierry MAY, Patrick MIAILHES, Thomas PERPOINT, Alix GREDER-BELAN, Brigitte ELHARRAR, Marie-Aude KHUONG, Marie POUPARD, Laurent BLUM, Christophe MICHAU, Thierry PRAZUCK, Patrick PHILIBERT, Laurence SLAMA, Hitoto HIKOMBO, Iuliana DARASTEANU, Pierre-Marie GIRARD, Jean-Claude ALVAREZ, Dominique MATHEZ, Pierre DE TRUCHIS, Roland LANDMAN, Jean-Luc MEYNARD, Laurence MORAND-JOUBERT, Sidonie LAMBERT, Damien LE DU, Christian PERRONNE, Lambert ASSOUMOU, Dominique COSTAGLIOLA, Jean-Claude MELCHIOR, Martin DURACINSKI, Ventzislava PETROV-SANCHEZ, Karine AMAT, Aïda BENALYCHERIF, Babacar SYLLA, Ambre GELLEY, Séverine GIBOWSKI, Guillaume LE MEUT, Rodolphe THIEBAUT, Nathan CLUMECK, Vincent LECLERCQ, Francesca CECCHERINI-SILBERSTEIN & Laurent DECOSTER. (2022) A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial. The Lancet HIV 9:2, pages e79-e90.
Crossref
Crossref
Jesús Troya, Carlos Dueñas, Idoia Irazola, Ignacio de los Santos, Sara de la Fuente, Desiré Gil, Cristina Hernández, María José Galindo, Julia Gómez, Elisabeth Delgado, Estela Moreno-García, Guillermo Pousada, Teresa Aldámiz, Jose Antonio Iribarren, José Manuel Guerra, Miguel Ángel Morán, Carlos Galera, Javier De La Fuente, Ana Peláez, Miguel Cervero, María Garcinuño, Marta Montero, Francisco Ceballos & Luis Buzón. (2022) Dolutegravir plus rilpivirine: benefits beyond viral suppression. Medicine 101:24, pages e29252.
Crossref
Crossref
Oluyinka Oladele Opaleye, Olusola Anuoluwapo Akanbi, Folakemi Abiodun Osundare, Bo Wang, Olufisayo Adesina, Adeolu Sunday Oluremi, Sola Thomas Sunday, Abiodun Akeem Akindele, Patrycja Klink & C. Thomas Bock. (2021) Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria. Virology Journal 18:1.
Crossref
Crossref
Daniele Armenia, Yagai Bouba, Roberta Gagliardini, Lavinia Fabeni, Vanni Borghi, Giulia Berno, Alessandra Vergori, Stefania Cicalini, Cristina Mussini, Andrea Antinori, Francesca Ceccherini‐Silberstein, Carlo Federico Perno & Maria Mercedes Santoro. (2021) Virological response and resistance profile in highly treatment‐experienced HIV‐1‐infected patients switching to dolutegravir plus boosted darunavir in clinical practice. HIV Medicine 22:6, pages 519-525.
Crossref
Crossref
Young Do Kwon, Xiangchun E. Wang, Michael F. Bender, Rong Yang, Yile Li, Krisha McKee, Reda Rawi, Sijy O’Dell, Nicole A. Schneck, Andrew Shaddeau, Baoshan Zhang, Frank J. Arnold, Mark Connors, Nicole A. Doria-Rose, Peter D. Kwong & Q. Paula Lei. (2021) Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography. Antibodies 10:2, pages 23.
Crossref
Crossref
Mariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo, Salvatore Martini, Paolo Chiodini, Simona Signoriello, Paolo Maggi & Nicola Coppola. (2021) Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis. Clinical Microbiology and Infection 27:1, pages 28-35.
Crossref
Crossref
Cynthia L. Gay, Dayna T. Neo, Aaron S. Devanathan, Joann D. Kuruc, Kara S. McGee, John L. Schmitz, Joe Sebastian, Nicholas J. Shaheen, Guido Ferrari, Mehri McKellar, Susan A. Fiscus, Charles B. Hicks, Kevin Robertson, Angela D.M. Kashuba, Joseph J. Eron & David M. Margolis. (2020) Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection. AIDS 34:13, pages 1923-1931.
Crossref
Crossref
Mattia Trunfio, Walter Rugge, Lorenzo Mighetto, Daniela Vai, Cristiana Atzori, Marco Nigra, Simone Domini, Enrica Borgogno, Giulia Guastamacchia, Stefano Bonora, Giovanni Di Perri & Andrea Calcagno. (2020) Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV. AIDS 34:13, pages 1899-1906.
Crossref
Crossref
Leonardo Calza, Vincenzo Colangeli, Marco Borderi, Diletta Testi, Bianca Granozzi, Isabella Bon, Maria Carla Re & Pierluigi Viale. (2020) Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy. Journal of Antimicrobial Chemotherapy 75:11, pages 3327-3333.
Crossref
Crossref
Jay Trivedi, Dinesh Mahajan, Russell J. Jaffe, Arpan Acharya, Debashis Mitra & Siddappa N. Byrareddy. (2020) Recent Advances in the Development of Integrase Inhibitors for HIV Treatment. Current HIV/AIDS Reports 17:1, pages 63-75.
Crossref
Crossref
Alberto Borghetti, Francesca Lombardi, Roberta Gagliardini, Gianmaria Baldin, Arturo Ciccullo, Davide Moschese, Arianna Emiliozzi, Simone Belmonti, Silvia Lamonica, Francesca Montagnani, Elena Visconti, Andrea De Luca & Simona Di Giambenedetto. (2019) Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice. BMC Infectious Diseases 19:1.
Crossref
Crossref
Jay Trivedi, Afsana Parveen, Farhana Rozy, Alapani Mitra, Chandralata Bal, Debashis Mitra & Ashoke Sharon. (2019) Discovery of 2-isoxazol-3-yl-acetamide analogues as heat shock protein 90 (HSP90) inhibitors with significant anti-HIV activity. European Journal of Medicinal Chemistry 183, pages 111699.
Crossref
Crossref
Vicente Soriano, Antonio Aguilera, Rocío Gonzalez, Felix Gomez-Gallego, Luisa Barea, Mercedes Treviño & Octavio Corral. (2019) Occult hepatitis B and HIV infection. European Journal of Gastroenterology & Hepatology 31:11, pages 1403-1407.
Crossref
Crossref
Angela Scala, Anna Piperno, Nicola Micale, Frauke Christ & Zeger Debyser. (2018) Synthesis and Anti-HIV Profile of a Novel Tetrahydroindazolylbenzamide Derivative Obtained by Oxazolone Chemistry. ACS Medicinal Chemistry Letters 10:4, pages 398-401.
Crossref
Crossref
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons & Carmen de Mendoza. (2019) Benefits of hepatitis C cure with antivirals: why test and treat?. Future Microbiology 14:5, pages 425-435.
Crossref
Crossref
Tomokazu Yoshinaga, Shigeru Miki, Shinobu Kawauchi-Miki, Takahiro Seki & Tamio Fujiwara. (2019) Barrier to Resistance of Dolutegravir in Two-Drug Combinations. Antimicrobial Agents and Chemotherapy 63:3.
Crossref
Crossref
Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti, Stefano Rusconi, Gaetana Sterrantino, Gabriella d'Ettorre, Manuela Colafigli, Sara Modica, Filippo Lagi, Andrea Giacomelli, Maria Vittoria Cossu, Sibilla Restelli, Andrea De Luca & Simona Di Giambenedetto. (2019) A Comparison between two Dolutegravir-Based two-drug Regimens as Switch Strategies in a Multicentre Cohort of HIV-1-Infected Patients. Antiviral Therapy 24:1, pages 63-67.
Crossref
Crossref
Hannah A. Blair. (2018) Dolutegravir/Rilpivirine: A Review in HIV-1 Infection. Drugs 78:16, pages 1741-1750.
Crossref
Crossref
Eungi Choi, Jayapal Reddy Mallareddy, Dai Lu & Srikanth Kolluru. (2018) Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase. Future Science OA 4:9, pages FSO338.
Crossref
Crossref
Daniele Armenia, Mauro Zaccarelli, Vanni Borghi, William Gennari, Domenico Di Carlo, Alberto Giannetti, Federica Forbici, Ada Bertoli, Caterina Gori, Lavinia Fabeni, Carmela Pinnetti, Raffaella Marocco, Alessandra Latini, Francesca Ceccherini-Silberstein, Claudio Maria Mastroianni, Cristina Mussini, Andrea Antinori, Carlo Federico Perno & Maria Mercedes Santoro. (2018) Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment. Journal of Clinical Virology 104, pages 61-64.
Crossref
Crossref
Amedeo F. Capetti, GianCarlo Orofino, Laura Paladini, Gaetana Sterrantino, Simona DiGiambenedetto, Giuseppe V. De Socio, Giovanni Cenderello, Maria V. Cossu & Giuliano Rizzardini. (2018) Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio?. AIDS 32:8, pages 1083-1084.
Crossref
Crossref
Sang-Ah Lee, Shin-Woo Kim, Hyun-Ha Chang, Hyejin Jung, Yoonjung Kim, Soyoon Hwang, Sujeong Kim, Han-Ki Park & Jong-Myung Lee. (2018) Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus. Infection & Chemotherapy 50:3, pages 252.
Crossref
Crossref
Rosario Palacios, M. Mayorga, C. M. González-Domenech, C. Hidalgo-Tenorio, C. Gálvez, L. Muñoz-Medina, J. de la Torre, A. Lozano, M. Castaño, M. Omar & Jesús Santos. (2018) Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study. Journal of the International Association of Providers of AIDS Care (JIAPAC) 17, pages 232595821876084.
Crossref
Crossref